Work

Intravenous Pembrolizumab Combined With Intravesical Bacillus Calmette–guérin (bcg) for Patients With Bcg-naïve “very High-risk” T1 Non-muscle Invasive Bladder Cancer Traditionally Recommended for Radical Cystectomy